These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17078590)

  • 1. [What is the frequency of cardiovascular risk factors and co-morbidity in patients with rheumatic diseases?].
    Bertin P
    Presse Med; 2006 Sep; 35(9 Spec No 1):1S5-9. PubMed ID: 17078590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frequency of cardiovascular risk factors and co-morbidity in patients with rheumatic diseases].
    Bertin P
    Presse Med; 2006 Sep; 35 Suppl 1():5-9. PubMed ID: 17870548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.
    Sfikakis PP; Bournia VK; Sidiropoulos P; Boumpas DT; Drosos AA; Kitas GD; Konstantonis G; Liossis SN; Manoussakis MN; Sakkas L; Tektonidou M; Tzioufas AG; Vlachoyiannopoulos PG; Kani C; Paterakis P; Litsa P; Vassilopoulos D
    Clin Exp Rheumatol; 2017; 35(4):579-585. PubMed ID: 28281458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.
    Castañeda S; Martín-Martínez MA; González-Juanatey C; Llorca J; García-Yébenes MJ; Pérez-Vicente S; Sánchez-Costa JT; Díaz-Gonzalez F; González-Gay MA;
    Semin Arthritis Rheum; 2015 Jun; 44(6):618-26. PubMed ID: 26058345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How to evaluate the cardiovascular and renal risk at the individual level?].
    Schaeverbeke T; Vicaut E; Cohen A; Ravaud P
    Presse Med; 2006 Sep; 35(9 Spec No 1):1S35-40. PubMed ID: 17078593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of renal dysfunction in patients with inflammatory arthropathies: strong association with cardiovascular diseases and not with anti-rheumatic therapies, inflammatory markers or duration of arthritis.
    Haroon M; Adeeb F; Devlin J; O Gradaigh D; Walker F
    Int J Rheum Dis; 2011 Aug; 14(3):255-60. PubMed ID: 21816021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the true incidence of COVID-19 in patients with rheumatic diseases?
    Favalli EG; Ingegnoli F; Cimaz R; Caporali R
    Ann Rheum Dis; 2021 Feb; 80(2):e18. PubMed ID: 32321723
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project.
    Martín-Martínez MA; Castañeda S; González-Juanatey C; Sánchez-Alonso F; García-Gómez C; López-González R; Babío-Herraiz J; Juan-Mas A; Moreno-Gil MP; Sánchez-González CO; Romera-Baurés M; Pinto-Tasende JA; Tornero-Molina J; Fábregas-Canales D; Llorca J; González-Gay MA;
    Clin Exp Rheumatol; 2019; 37(5):731-739. PubMed ID: 30620291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular comorbidities in rheumatic diseases].
    Kellner H
    MMW Fortschr Med; 2009 Nov; 151(48):48. PubMed ID: 20085065
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-steroidal anti-inflammatory drugs and cardiovascular risk--a rheumatologist's.
    Whitelaw D
    S Afr Med J; 2007 Dec; 97(12):1230. PubMed ID: 18264598
    [No Abstract]   [Full Text] [Related]  

  • 11. [NSAID prescription in patients with rheumatoid arthritis and cardiovascular disease].
    Pavlović R; Curković B; Babić-Naglić D; Kehler T
    Reumatizam; 2006; 53(1):22-4. PubMed ID: 17580545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cardiovascular comorbidities on work participation in rheumatic diseases: a prospective cohort study among working individuals.
    van der Burg LR; Boonen A; van Amelsvoort LG; Jansen NW; Landewé RB; Kant I
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):157-63. PubMed ID: 23926070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rheumatic diseases as risk factors for cardiovascular disease].
    Nurmohamed MT; Voskuyl AE; van der Horst-Bruinsma IE; Dijkmans BA
    Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1921-4. PubMed ID: 16999275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutropenia in the Elderly: A Rheumatology Perspective.
    Yeoh SA; Fox C; Hull R
    Drugs Aging; 2016 Aug; 33(8):585-601. PubMed ID: 27402172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cardiovascular risk factors in different rheumatic diseases compared with the general population.
    Meek IL; Picavet HS; Vonkeman HE; Verschuren WM; van de Laar MA
    Rheumatology (Oxford); 2013 Jan; 52(1):210-6. PubMed ID: 22847678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists.
    Greenberg JD; Bingham CO; Abramson SB; Reed G; Sebaldt RJ; Kremer J
    Arthritis Rheum; 2005 Feb; 53(1):12-7. PubMed ID: 15696570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications - A National Population-Based Cohort Study.
    Chiu HY; Huang HL; Li CH; Chen HA; Yeh CL; Chiu SH; Lin WC; Cheng YP; Tsai TF; Ho SY
    PLoS One; 2015; 10(9):e0136508. PubMed ID: 26406879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.
    Li C; Wang XR; Ji HJ; Zhang XY; Li XF; Wang LZ; Wang CH; Wang YF; Yang R; Wang GC; Lu X; Zhu P; Chen LN; Jin HT; Liu JT; Liu XY; Sun L; Chen HY; Wei P; Wang JX; Cui LF; Shu R; Liu BL; Zhang ZL; Li GT; Li ZB; Yang J; Li JF; Jia B; Zhang FX; Tao JM; Han SL; Lin JY; Wei MQ; Liu XM; Ke D; Hu SX; Ye C; Yang XY; Li H; Huang CB; Gao M; Lai B; Li XF; Song LJ; Wang Y; Wang XY; Tang YD; Su Y; Mu R; Li ZG
    Clin Rheumatol; 2017 May; 36(5):1023-1029. PubMed ID: 28342151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory arthritis as a novel risk factor for cardiovascular disease.
    John H; Kitas G
    Eur J Intern Med; 2012 Oct; 23(7):575-9. PubMed ID: 22841864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
    Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.